Antitumor activity of HER1/EGFR tyrosine kinase inhibitor erlotinib, alone and in combination with CPT-11 (irinotecan) in human colorectal cancer xenograft models

By Chen Jianping   Smith Melissa   Kolinsky Kenneth   Adames Violeta   Mehta Nila   Fritzky Luke   Rashed Mohammad   Wheeldon Eric   Linn Michael   Higgins Brian  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 5, 2007-04 ,pp. : 651-659

Springer Publishing Company

Access to resources Recommend Favorite

Antitumor activity of trastuzumab in combination with chemotherapy in human gastric cancer xenograft models

By Fujimoto-Ouchi Kaori   Sekiguchi Fumiko   Yasuno Hideyuki   Moriya Yoichiro   Mori Kazushige   Tanaka Yutaka  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 6, 2007-06 ,pp. : 795-805

Springer Publishing Company

Access to resources Recommend Favorite

Antitumor activity of Endostar combined with radiation against human nasopharyngeal carcinoma in mouse xenograft models

By            

Oncology Letters, Vol. 4, Iss. 5, 2012-01 ,pp. : 976-980

Spandidos Publications

Access to resources Recommend Favorite

Improved Anti-Tumor Activity of Novel Highly Bioactive Liposome-Bound TRAIL in Breast Cancer Cells

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 11, Iss. 2, 2016-04 ,pp. : 197-214

Bentham Science Publishers

Access to resources Recommend Favorite

The Experimental Antitumor Agents Phortress and Doxorubicin are Equiactive Against Human‐Derived Breast Carcinoma Xenograft Models

By Fichtner Iduna  

Breast Cancer Research and Treatment, Vol. 87, Iss. 1, 2004-09 ,pp. : 97-107

Springer Publishing Company

Access to resources Recommend Favorite